This podcast episode explores Philip Morris's entry into the healthcare industry in 2021, which raised concerns in the pharmaceutical industry and public health community. Despite these concerns, Philip Morris acquired Victoria, a pharmaceutical company, sparking further criticism about the potential conflict of interest. However, the healthcare business has faced challenges, forcing Philip Morris to consider selling a stake and shifting back to tobacco alternatives.
